Solstice Neurosciences

Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice’s first product named Myobloc® (rimabotulinumtoxinB) Injection in the...

Total money raised: $93M

94080 701 Gateway Boulevard
Suite 250

South San Francisco
South San Francisco

Phone: 650-243-4400

Updated on Oct 15, 2013
Solstice Neurosciences at CrunchBase

August, 2010

Solstice Neurosciences was acquired by US WorldMeds
for $35.7M

US WorldMeds Acquires Solstice Neurosciences

November, 2006

Solstice Neurosciences raised $85M in a Series B round from Highland Capital Partners, Thomas, McNerney & Partners, Investor Growth Capital, Morgan Stanley Venture Partners, and Oxford Bioscience Partners

Solstice Neurosciences Raises $85 Million in Private Financing

July, 2005

Solstice Neurosciences raised $8M in unattributed round from Morgan Stanley Venture Partners, Thomas, McNerney & Partners, Oxford Bioscience Partners, and Investor Growth Capital